User contributions for Kosar Doraghi
Jump to navigation
Jump to search
8 June 2024
- 23:0223:02, 8 June 2024 diff hist +15,628 N Xolremdi Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=mavorixafor |aOrAn=a |drugClass=CXC chemokine receptor 4 (CXCR4) antagonist |indicationType=treatment |indication=patients 12 years of age and older with WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis) to increase the number of circulating mature neutrophils and lymphocytes. |hasBlackBoxWarning=Yes |adverseReactions=thrombocytopenia, pityr..." current
- 22:5222:52, 8 June 2024 diff hist 0 N File:IMG 1240.jpeg No edit summary current
- 22:5022:50, 8 June 2024 diff hist 0 N File:IMG 1239.jpeg No edit summary current
- 22:4922:49, 8 June 2024 diff hist 0 N File:IMG 1238.jpeg No edit summary current
2 June 2024
- 03:2803:28, 2 June 2024 diff hist +581 WINREVAIR No edit summary current
- 02:5402:54, 2 June 2024 diff hist 0 N File:IMG 1235.jpeg No edit summary current
- 02:5302:53, 2 June 2024 diff hist 0 N File:IMG 1234.jpeg No edit summary current
- 02:5202:52, 2 June 2024 diff hist 0 N File:IMG 1231.jpeg No edit summary current
- 02:5102:51, 2 June 2024 diff hist 0 N File:IMG 1232.jpeg No edit summary current
- 02:4902:49, 2 June 2024 diff hist 0 N File:IMG 1230.jpeg No edit summary current
- 02:4902:49, 2 June 2024 diff hist 0 N File:IMG 1227.jpeg No edit summary current
- 02:4802:48, 2 June 2024 diff hist 0 N File:IMG 1236.jpeg No edit summary current
- 02:4602:46, 2 June 2024 diff hist 0 N File:IMG 1237.jpeg No edit summary current
- 02:4102:41, 2 June 2024 diff hist 0 N File:IMG 1226.jpeg No edit summary current
1 June 2024
- 03:2103:21, 1 June 2024 diff hist +15 Template:KDRG No edit summary current
- 03:2003:20, 1 June 2024 diff hist +16,566 N WINREVAIR Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=sotatercept-csrk |aOrAn=an |drugClass=activin signaling inhibitor |indicationType=treatment |indication=adults with pulmonary arterial hypertension (PAH, WHO Group 1) to increase exercise capacity, improve WHO functional class (FC) and reduce the risk of clinical worsening events |hasBlackBoxWarning=Yes |adverseReactions=headache, epistaxis, rash, telangiect..."
23 May 2024
- 02:0102:01, 23 May 2024 diff hist +18 Template:KDRG No edit summary
- 02:0002:00, 23 May 2024 diff hist +16,419 N Aprocitentan Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar.Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=aprocitentan |aOrAn=an |drugClass=endothelin receptor antagonist |indicationType=treatment |indication=hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult patients who are not adequately controlled on other drugs |hasBlackBoxWarning=Yes |adverseReactions=edema/fluid retention and anemia |blackBoxWarningTitle=W..." current
- 02:0002:00, 23 May 2024 diff hist −3 Template:KDRG No edit summary
- 01:4901:49, 23 May 2024 diff hist 0 N File:IMG 1225.jpeg No edit summary current
- 01:2801:28, 23 May 2024 diff hist 0 N File:IMG 1224.jpeg No edit summary current
- 01:2801:28, 23 May 2024 diff hist 0 N File:IMG 1223.jpeg No edit summary current
19 May 2024
- 03:5403:54, 19 May 2024 diff hist +1,728 Chronic obstructive pulmonary disease history and symptoms No edit summary current
14 May 2024
- 04:5504:55, 14 May 2024 diff hist +52 Somatrogon-ghla No edit summary current
12 May 2024
- 21:0621:06, 12 May 2024 diff hist +47 Template:KDRG No edit summary
- 21:0421:04, 12 May 2024 diff hist +215 Somatrogon-ghla No edit summary
- 20:5220:52, 12 May 2024 diff hist +13,854 Chronic renal failure overview No edit summary current
- 19:3519:35, 12 May 2024 diff hist 0 N File:IMG 1208.jpeg No edit summary current
- 19:3319:33, 12 May 2024 diff hist 0 N File:IMG 1207.jpeg No edit summary current
- 19:3219:32, 12 May 2024 diff hist 0 N File:IMG 1204.jpeg No edit summary current
- 19:3019:30, 12 May 2024 diff hist 0 N File:IMG 1202.jpeg No edit summary current
- 19:2819:28, 12 May 2024 diff hist 0 N File:IMG 1200.jpeg No edit summary current
- 19:2419:24, 12 May 2024 diff hist 0 N File:IMG 1214.jpeg No edit summary current
- 05:3005:30, 12 May 2024 diff hist +12,476 N Somatrogon-ghla Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.con] |genericName=somatrogon-ghla |aOrAn=a |drugClass=human growth hormone analog |indicationType=treatment |indication=pediatric patients aged 3 years and older who have growth failure due to inadequate secretion of endogenous growth hormone |hasBlackBoxWarning=Yes |adverseReactions=injection site reactions, nasopharyngitis, headache, pyrexia, anemia, cough, v..."
- 05:1505:15, 12 May 2024 diff hist 0 N File:IMG 1198.jpeg No edit summary current
- 05:1305:13, 12 May 2024 diff hist 0 N File:IMG 1215.jpeg No edit summary current
8 May 2024
- 21:3821:38, 8 May 2024 diff hist +174 Template:KDRG No edit summary
- 21:3821:38, 8 May 2024 diff hist +11 EXXUA No edit summary current
- 21:3221:32, 8 May 2024 diff hist +11,561 N EXXUA Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=Gepirone |aOrAn=a |drugClass=extended-release tablets |indicationType=treatment |indication=major depressive disorder (MDD) in adults |hasBlackBoxWarning=Yes |adverseReactions=dizziness, nausea, insomnia, abdominal pain, and dyspepsia |blackBoxWarningTitle=WARNING: SUICIDAL THOUGHTS AND BEHAVIORS |blackBoxWarningBody=SEE FULL PRESCRIBING INFORMATION FOR..."
- 21:2721:27, 8 May 2024 diff hist 0 N File:IMG 1195.jpeg No edit summary current
- 21:2621:26, 8 May 2024 diff hist 0 N File:IMG 1196.jpeg No edit summary current
- 21:1921:19, 8 May 2024 diff hist 0 N File:IMG 1194.jpeg No edit summary current
3 May 2024
- 22:5722:57, 3 May 2024 diff hist +11,950 N Xacduro- sulbactam and durlobactam Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=sulbactam and durlobactam |aOrAn=a |drugClass=co-packaged product containing sulbactam, a beta-lactam antibacterial and beta lactamase inhibitor, and durlobactam, a beta lactamase inhibitor, |indicationType=treatment |indication=hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by susceptible isolates of Acin..." current
1 May 2024
- 15:4615:46, 1 May 2024 diff hist +15,269 N Nirsevimab Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=Nirsevimab |aOrAn=a |drugClass=respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor |indicationType=prevention |indication=RSV lower respiratory tract disease in: Neonates and infants born during or entering their first RSV season, and children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season |hasBlackBo..." current
- 15:3115:31, 1 May 2024 diff hist 0 N File:IMG 1185.jpeg No edit summary current
- 15:2915:29, 1 May 2024 diff hist 0 N File:IMG 1187.jpeg No edit summary current
27 April 2024
- 00:4900:49, 27 April 2024 diff hist +2,903 Chronic obstructive pulmonary disease history and symptoms No edit summary
24 April 2024
- 23:1723:17, 24 April 2024 diff hist +5,051 Endocarditis overview No edit summary current
- 23:0423:04, 24 April 2024 diff hist 0 N File:IMG 1177.jpeg No edit summary current
- 22:5922:59, 24 April 2024 diff hist 0 N File:IMG 1176.jpeg No edit summary current